In a groundbreaking move, Boehringer Ingelheim has sealed the deal to acquire T3 Pharmaceuticals, a dynamic Swiss biotech company, for a staggering amount of up to 450 million CHF. This strategic move signals a major leap forward in the field of cancer treatment. T3 Pharma boasts a cutting-edge therapy platform utilizing live bacteria to deliver […]
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, has announced the completion of its oversubscribed Series C equity financing raising EUR 67.5m (USD 72m) from a syndicate
LASCCO, a biomedical-technology company, and Abionic, a nanotechnology company, both based at the Biopôle of Lausanne, entered into a licensing agreement with Fapon Biotech, a global leading life sciences company, based in Dongguan (China)
Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) has acquired the 68.0% of the shares in Swiss pharmaceutical company Osmopharm and has disinvested the 76.4% in Egyptian pharmaceutical manufacturer SPIMACO Misr for Pharmaceutical Industries. The Transaction, with
Partners Group, a renowned global private markets firm, acting on behalf of its clients, has agreed to acquire ROSEN Group, a global provider of mission-critical inspection services for energy infrastructure assets, from its founder, Hermann
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, has announced the completion of its oversubscribed Series C equity financing raising €67.5 million ($72 million) from a syndicate of renowned
Solar Impulse Foundation launches RUNWAY, a new matchmaking tool for cleantech that allows to direct capital towards clean and efficient ventures to create an economy evolving within planetary boundaries. The platform will be live on 28
Nanogence closed its Series A financing round, securing financing from a consortium of investors. The consortium was led by CirCap, an investment platform providing strategic private capital to innovative companies in climate-tech, healthcare and education,
Baker McKenzie Switzerland advised Arab Bank Switzerland on its acquisition of the Quarz’Up project, a first-class, multifunctional commercial development project in Vernier near Geneva in a share deal. The Quarz’Up project will be
Competition & Antitrust
Corporate
Lenz & Staehelin: Vencora announces PTO for Crealogix publicly held
Vencora and CREALOGIX, a global player in digital banking technology, jointly announced today that they have entered into a definitive transaction agreement, under which Vencora agreed to submit an all-cash public tender offer to acquire
